Tedeschi Elisa, Antoniazzi Franco, Venturi Giacomo, Zamboni Giorgio, Tatò Luciano
Dept. of Mother and Child, Biology and Genetics, Pediatric Section, University of Verona, Italy.
Pediatr Endocrinol Rev. 2006 Sep;4(1):40-6.
Osteogenesis Imperfecta is a genetic disorder of increased bone fragility and low bone mass. Most cases are caused by a mutation in one of the two genes coding for the type I collagen protein. The correct clinical diagnosis of OI can be difficult sometimes, because of the wide phenotypic range. Therefore collagen I genes mutation identification can be helpful. We screened 23 patients by direct sequencing of the exons encoding the collagen protein. We identified 18 different mutations, while 5 cases were negative because of an uncertain clinical diagnosis or an atypical form of OI not related to collagen I genes. The current medical and pharmaceutical treatments are only symptomatic and do not alter the course of collagen mutations. Cells and gene therapies as potential treatments for OI have therefore to be actively investigated.
成骨不全症是一种遗传性疾病,其特征为骨脆性增加和骨量低。大多数病例是由编码I型胶原蛋白的两个基因之一发生突变引起的。由于OI的表型范围广泛,有时正确的临床诊断可能会很困难。因此,I型胶原蛋白基因突变鉴定可能会有所帮助。我们通过对编码胶原蛋白的外显子进行直接测序,对23名患者进行了筛查。我们鉴定出18种不同的突变,而5例由于临床诊断不确定或与I型胶原蛋白基因无关的非典型OI形式而呈阴性。目前的医学和药物治疗仅为对症治疗,不会改变胶原蛋白突变的进程。因此,作为OI潜在治疗方法的细胞和基因疗法必须积极研究。